comprehensive -WSS

comprehensive

author：focus 2025-09-28 14:50:01 - browse：25

Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT — Adobe

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： UCB departs biotech trade group BIO

entertainment

WSS

Mitch McConnell episode has important public health takeaway

Antibiotic resistance and the global rise in human conflict

Mega Millions pot grows to $1.25 billion after no winner

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Wildfire pollution widens asthma inequities on Long Island

hotspot

comprehensive

hotspot

Medical records are filled with copy

Ahead of JPM, here's who's profiting most in health care

Supreme Court strikes down use of affirmative action

AdventHealth escalates lawsuit against insurance vendor Multiplan

Trump demands the U.S. pay no more for drugs than other countries … again

New safety details link Apellis eye drug to rare cases of blindness

Walensky prepares to leave CDC — and Congress — behind

Ahead of JPM, here's who's profiting most in health care

Malaria cases in Florida and Texas: Here’s what you need to know

Micronoma's microbiome cancer diagnostic approach under fire

focus

The biotech scorecard for Q1: 17 stock

JPM: CVS says Medicare Advantage patients are impacting profits

Videos point to link between seizures and unexplained toddler deaths

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Chronically ill young patients struggle to find fertility info

No plane should take off without an EpiPen onboard

focus

entertainment

hotspot

hotspot